The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
4.130
+0.210 (5.36%)
At close: Jan 6, 2026, 4:00 PM EST
4.160
+0.030 (0.73%)
After-hours: Jan 6, 2026, 7:51 PM EST
The Oncology Institute Market Cap
The Oncology Institute has a market cap or net worth of $406.31 million as of January 6, 2026. Its market cap has increased by 2,730.24% in one year.
Market Cap
406.31M
Enterprise Value
482.28M
1-Year Change
2,730.24%
Ranking
Category
Stock Price
$4.13
Market Cap Chart
Since July 23, 2021, The Oncology Institute's market cap has increased from $990.00 to $406.31M, an increase of 41,041,812.53%. That is a compound annual growth rate of 1,716.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 385.65M | 10.11% |
| Dec 31, 2025 | 350.24M | 1,400.09% |
| Dec 31, 2024 | 23.35M | -84.48% |
| Dec 29, 2023 | 150.45M | 22.52% |
| Dec 30, 2022 | 122.80M | -82.81% |
| Dec 31, 2021 | 714.18M | 72,139,108.08% |
| Jul 23, 2021 | 990.00 | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |